4E-BP2 activators belong to a specific chemical class that plays a pivotal role in regulating cellular processes, particularly in the realm of protein synthesis. The term 4E-BP2 refers to the eukaryotic translation initiation factor 4E-binding protein 2, a key component in the intricate machinery governing the initiation of mRNA translation. This class of compounds exerts its influence by modulating the activity of 4E-BP2, a protein that, under normal circumstances, inhibits translation initiation by binding to the eukaryotic translation initiation factor 4E (eIF4E). eIF4E is a crucial factor in the initiation of cap-dependent translation, a process essential for the synthesis of numerous proteins involved in cellular functions and signaling pathways.
The activation of 4E-BP2 by compounds within this chemical class represents a molecular mechanism with potential implications for cellular homeostasis and responses to various stimuli. By fine-tuning the activity of 4E-BP2, these compounds may exert regulatory control over the translation of specific mRNAs, ultimately influencing the synthesis of proteins involved in cellular growth, proliferation, and survival. As our understanding of the intricate dynamics of translational control deepens, the development and exploration of 4E-BP2 activators may offer valuable insights into the fundamental processes governing gene expression and cellular function, shedding light on new avenues for research and potential applications in diverse biological contexts.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates the PI3K/Akt/mTOR pathway, which phosphorylates and inactivates 4E-BP2, leading to its dissociation from eIF4E and the subsequent initiation of cap-dependent translation. | ||||||
L-Leucine | 61-90-5 | sc-364173 sc-364173A | 25 g 100 g | $21.00 $62.00 | ||
Leucine stimulates the mTOR pathway, which phosphorylates 4E-BP2, reducing its affinity for eIF4E and thus enhances the initiation of mRNA translation. | ||||||
PI-103 | 371935-74-9 | sc-203193 sc-203193A | 1 mg 5 mg | $33.00 $131.00 | 3 | |
PI-103 inhibits PI3K and mTOR, causing a reduction in 4E-BP2 phosphorylation under certain conditions; however, paradoxically, it can lead to an overcompensation effect, enhancing 4E-BP2 phosphorylation and activity. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol has been shown to activate SIRT1, which can indirectly enhance the activity of the mTOR pathway leading to phosphorylation of 4E-BP2 under certain contexts. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Glucocorticoids like dexamethasone can activate mTOR signaling in certain cell types, leading to increased phosphorylation and inactivation of 4E-BP2. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $67.00 $156.00 | 16 | |
This Hsp90 inhibitor can modulate the PI3K/Akt/mTOR pathway, leading to increased phosphorylation of 4E-BP2 in certain conditions. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
As a PI3K inhibitor, LY294002 can, in certain contexts, result in feedback activation of the insulin signaling pathway, leading to increased phosphorylation of 4E-BP2. | ||||||
PF 4708671 | 1255517-76-0 | sc-361288 sc-361288A | 10 mg 50 mg | $179.00 $700.00 | 9 | |
Inhibition of S6K1 can relieve feedback inhibition on PI3K/Akt pathway, leading to enhanced phosphorylation of 4E-BP2 and activation of cap-dependent translation. | ||||||